Revenue Breakdown
Composition ()
No data
Revenue Streams
Globus Medical Inc (GMED) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Musculoskeletal Solutions , accounting for 96.4% of total sales, equivalent to $741.01M. Another important revenue stream is Enabling Technologies . Understanding this composition is critical for investors evaluating how GMED navigates market cycles within the Medical Equipment, Supplies & Distribution industry.
Profitability & Margins
Evaluating the bottom line, Globus Medical Inc maintains a gross margin of 64.85%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 21.94%, while the net margin is 17.01%. These profitability ratios, combined with a Return on Equity (ROE) of 12.29%, provide a clear picture of how effectively GMED converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, GMED competes directly with industry leaders such as MASI and PEN. With a market capitalization of $12.91B, it holds a significant position in the sector. When comparing efficiency, GMED's gross margin of 64.85% stands against MASI's 59.95% and PEN's 68.02%. Such benchmarking helps identify whether Globus Medical Inc is trading at a premium or discount relative to its financial performance.
